Salta al menu principale di navigazione Salta al contenuto principale Salta al piè di pagina del sito

Articles

Online First

Acupuncture in Integrated Cancer Therapy: Scientific Evidence, Clinical Appropriateness and Care Model of the Tuscan Health Service

DOI
https://doi.org/10.3280/pnei2026oa24174
Inviata
novembre 6, 2026
Pubblicato
18-11-2026

Abstract

Integrated oncology represents a care model oriented towards combining conventional
oncological treatments with complementary interventions selected on the basis of available
evidence, safety and individual patient needs. In this context, acupuncture is one of the most
studied methods for the management of neoplasia-related symptoms and adverse effects associated
with surgery, chemotherapy, radiotherapy and endocrine therapies. The main areas of interest
include pain, cancer-related fatigue, nausea and vomiting, chemotherapy-induced peripheral
neuropathy, arthralgias associated with aromatase inhibitors, hot flashes, xerostomia, sleep disturbances
and psychoemotional symptoms. Its role must be defined within supportive care and
not as an alternative antineoplastic treatment. In parallel, experimental research has proposed
mechanisms including neuromodulation, neurovegetative regulation, purinergic signaling,
modulation of inflammatory mediators and neuro-immuno-endocrine interactions. Traditional
Chinese Medicine offers a further interpretative paradigm based on the concepts of Zheng Qi,
Yuan Qi and Fu Zheng; the comparison with biomedicine can generate research hypotheses, as
long as unproven equivalences are avoided. Of particular interest is the experience of the Tuscan
Health Service and the USL Toscana Sud Est, where integrated oncology has been progressively
PNEI review – ISSNe 2532-2826 ‒ DOI: 10.3280/pnei2026oa24174
Copyright © FrancoAngeli This work is released under Creative Commons Attribution ‒ Non-Commercial –
No Derivatives License. For terms and conditions of usage please see: http://creativecommons.org
2
structured through multi-professional pathways, acupuncture programs and research projects.
The observational data collected in the services represent a real-world heritage of potential interest,
although they require a reading consistent with the limits of uncontrolled studies.

Riferimenti bibliografici

  1. Cracolici F. (2026). “Acupuncture in integrated cancer therapy: evidence and experiences in the Tuscan health service”. Scientific and educational material unpublished.
  2. Society for Integrative Oncology (2026). SIO Practice Guidelines. Integrative Oncology. Available on-line: https://integrativeonc.org/practice-guidelines/ (accessed October 28).
  3. Mao J.J., Ismaila N., Bao T. et al. (2022). Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology-ASCO Guideline. J Clin Oncol., 40(34): 3998-4024.
  4. Carlson L.E., Ismaila N., Addington E.L. et al. (2023). Integrative Oncology Care of Symptoms of Anxiety and Depression in Adults with Cancer: Society for Integrative Oncology-ASCO Guideline. J Clin Oncol., 41(28): 4562-4591.
  5. Bower J.E., Lacchetti C., Alici Y. et al. (2024). Management of Fatigue in Adult Survivors of Cancer: ASCO-Society for Integrative Oncology Guideline Update. J Clin Oncol., 42(20): 2456-2487. DOI: 10.1200/JCO.24.00541.
  6. Yeh M.L., Liao R.W., Yeh P.H., Lin C.J. & Wang Y.J. (2024). Acupuncture-related interventions im-prove chemotherapy-induced peripheral neuropathy: systematic review and network meta-analysis. BMC Complement Med Ther., 24: 310. DOI: 10.10.1186/s12906-024-04603-1.
  7. Goldman N., Chen M., Fujita T. et al. (2010). Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Nat Neurosci., 13(7): 883-888.
  8. de Valois, B., Young, T., Zollman, C. et al. (2024). Acupuncture in cancer care: recommendations for safe practice (peer-reviewed expert opinion). Support Care Cancer, 32: 229. DOI: 10.1007/s00520-024-08386-6
  9. Höxtermann M.D., Haller H., Jänig C. et al. (2022). Safety of acupuncture in oncology: a systematic review and meta-analysis of randomized controlled trials. Cancer., 128: 2159-2173.
  10. PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. Acupuncture (PDQ®): Health Professional Version. 2024 Nov 1. In: PDQ Cancer Information Summaries [Inter-net]. Bethesda (MD): National Cancer Institute (US); 2002–. PMID: 26389159.
  11. Demakakos P., Chrousos G.P. & Biddulph J.P. (2018). Childhood experiences of parenting and can-cer risk at older ages: findings from the English Longitudinal Study of Ageing (ELSA). Int J Public Health, 63(7): 823-832. DOI: 10.10.1007/s00038-018-1117-3.
  12. Cole S.W., Levine M.E., Arevalo J.M.G., Ma J., Weir D.R. & Crimmins E.M. (2015). Loneliness, eu-daimonia, and the human conserved transcriptional response to adversity. Psychoneuroendocrinology, 62: 11-17.
  13. Sarma E.A., Kawachi I., Poole E.M. et al. (2018). Social integration and survival after diagnosis of colorectal cancer. Cancer., 124: 833-840.
  14. Tuscany Region. Resolution no. 418/2015: integration of complementary medicines into the Tuscan oncology network.
  15. Tuscany Region. Decree no. 2986 of 26 February 2021 and regional care pathway relating to inte-grated medicine in oncology.